Medical specialists and pharmaceutical industry‐sponsored research: a survey of the Australian experience-Reference-Cited by-同舟云学术

Medical specialists and pharmaceutical industry‐sponsored research: a survey of the Australian experience

Published:2005-06 Issue:11 Volume:182 Page:557-560
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Henry David A¹,Hill Suzanne R¹,Doran Evan¹,Newby David A¹,Henderson Kim M¹,Maguire Jane¹,Stokes Barrie J¹,Kerridge Ian H¹,McNeill Paul M²,Day Richard O³,Macdonald Graham J⁴

Affiliation:

1. School of Medical Practice and Population Health, and School of Biomedical Sciences, University of Newcastle, Newcastle, NSW.

2. Centre for Values, Ethics and the Law in Medicine, University of Sydney, Sydney, NSW.

3. University of New South Wales, Sydney, NSW.

4. Merck Sharp & Dohme (Australia), Sydney, NSW.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2005.tb06813.x

Reference15 articles.

1. Doctors and Drug Companies

2. Uneasy Alliance — Clinical Investigators and the Pharmaceutical Industry

3. Confronting conflict of interest in research organisations: time for national action

4. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

5. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review;Cochrane Evidence Synthesis and Methods;2023-04-27

2. Prevalence of Research Misconduct and Questionable Research Practices: A Systematic Review and Meta-Analysis;Science and Engineering Ethics;2021-06-29

3. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression;PLOS Medicine;2020-12-29

4. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials;BMJ;2019-04-09

5. Research Integrity and Responsible Conduct of Research;Keys to Running Successful Research Projects;2018